Emerging Trends in Diagnosis for COVID-19
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1679
Special Issue Editor
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic has caused high number of fatalities as well as economic and societal impacts. For a prompt return to previous levels of social interaction and business, virus spread must be kept under control; to achieve this, the development of new approaches for virus testing will be centralized. Diagnostic screening should be performed at mass scale and repeated over time. Different types of diagnostic tests are now available, with alternative methods and benefits. As monitoring capacity is limited, there is a demand for new strategies that could greatly increase laboratory efficiency while maintaining the benefits of time and cost effectiveness.
This Special Issue aims to focus on the increasing need for multidisciplinary approaches in which clinical and diagnostic concerns and insights incorporate to develop new efficient surveillance strategies, tailored to the characteristics of different monitoring contexts.
Dr. Chia-Yu Chi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- molecular testing
- antigenic testing
- clinical manifestations
- mortality